| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. | J Acquir Immune Defic Syndr | 2001 | 1.63 |
| 2 | Bacterial vaginosis and intravaginal practices: association with HIV. | Cent Afr J Med | 2005 | 0.92 |